UC Professor Advocated for New Law on HIV Positive Organ Donation
CINCINNATIUniversity of Cincinnati (UC) research professor of medicine Rita Alloway, PharmD, has spent years working to update a 20-year ban on HIV positive organ donationand her efforts, along with those of dozens of othersare being rewarded today with the signing of the HOPE Act into law by President Barack Obama.
The HOPE (HIV Organ Policy Equity) Act ends the federal ban on research into organ donations from HIV-positive donors to HIV-positive recipients, and paves the way for eventual transplantation of those organs to help HIV-positive recipients in need of a new liver, kidney, or potentially other organs.
Alloway, who calls todays signing "very rewarding, advocated for the act in her role as board and public policy committee member of the American Society of Transplantation, an international organization of transplant professionals. Alloway also directs UCs transplant clinical research program.
She says that allowing research into positive-to-positive donationsand creating safeguards and standards for such donationswill help to expand the pool of available organs for the more than 100,000 patients currently on the waiting list in the United States.
"The current rate limiting factor for patients awaiting transplant is the availability of a donor organ, she says. "Medically-sound efforts to increase the donor pool, such as the HOPE Act, will dramatically decrease wait times for HIV positive recipients, and thus provide more organs within the organ pool.
A study published in the American Journal of Transplantation estimated that allowing organ transplants from HIV-positive donors to HIV-positive recipients could increase the organ pool by 500 to 600 donors a year, saving hundreds of lives.
From 2003 to 2009, UC participated in a multicenter collaborative studying transplantation in HIV infected patients. The study, led locally by professors of medicine Prabir Roy-Chaudhury, MD, PhD, and Kenneth Sherman, MD, has led to many publications advancing this area of patient care.
"The need for increased donor has always been the Achilles heel for transplantation, says Alloway. "Specifically for the HIV transplant population, the advent of effective HIV treatments, and research proving HIV positive transplant patients have similar outcomes post-transplant, has allowed transplantation to be a viable option for these patients.
Additionally, the HOPE Act requires the national organ procurement and transplantation network (OPTN) to develop standards ensuring positive-to-positive transplantation does not impact the safety of the organ transplantation network. It also amends federal criminal law on HIV transmission to clarify that positive-to-positive donations are not barred.
The bipartisan legislation, sponsored by U.S. Sens. Barbara Boxer (D-Calif.) and Tom Coburn (R-Okla.) and 13 other senators, passed the U.S. Senate in June and was approved by the House of Representatives Tuesday, Nov. 12. The House bill was sponsored by Reps. Lois Capps (D-Calif.) and Andy Harris (R-Md.).
Tags
Related Stories
Certain weather patterns can trigger migraines
June 8, 2026
Certain weather patterns really do trigger migraine headaches — and the incidence is more common in the Midwest. As WGN 9 in Chicago recently reported, researchers at the University of Cincinnati College of Medicine have identified two specific weather patterns associated with an increased risk of headaches.
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.